Cardiologist, lipidologist, CEO of NewAmsterdam Pharma

Michael Davidson

Michael Davidson is a world-renowned cardiologist and lipidologist who serves as the founding CEO of NewAmsterdam Pharma. His research focuses on lipid metabolism, cardiovascular prevention, and the genetics of atherosclerosis.

Known For

LipidologyCETP inhibition researchCardiovascular prevention

Canon

ApoB: A Superior Predictor of Cardiovascular Risk Than LDL Cholesterol

Curious

APOE Genotype Is the Strongest Common Genetic Risk Factor for Late-Onset Alzheimer's Disease

Curious

Episodes

##407 ‒ Preventing cardiovascular and Alzheimer's disease: lowering LDL early, APOE4, and promising new therapies | Michael Davidson, M.D.Sep 14, 2026